Entity type
Individual
Filer Snapshot
Daniel Lang
CIK 0001895384. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
3
Latest filing
19 Sep 2022
Industry
n/a
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: Forms 3/4/5 owner position for ATNXQ. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
ATNXQ
16 Sep 2022 · $111K
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
4 filed on 19 Sep 2022 for CIK 0001895384.
- Parsed SEC ownership signals
-
Parsed SEC ownership coverage
These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.
Forms 3/4/5 positions$111KReporting-owner positions with enough filing detail to estimate value.
Forms 3/4/5 position value
3/4/5$111KEstimated from parsed Forms 3/4/5 when filings include enough share and price data.
Source: Forms 3/4/5Confidence: Estimated when price data is availableLargest linked holdings
Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.
ATNXQHow to read these SEC ownership signals
- Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
- Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
- Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
- Business address
- C/O Athenex, Inc. Conventus Building, 1001 Main St. Ste. 600, Buffalo, NY, 14203
Ownership signals
CIK-linked ownership evidence from parsed SEC filings.
1 signal
At a glance
Names, identifiers, and filing context for this profile.
1 identity field
Filer intelligence
What SEC filings say about Daniel Lang
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Forms 3/4/5 show insider context for ATNXQ worth $111K.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Forms 3/4/5 insider context
ATNXQ
16 Sep 2022 · Pres Cell Therapy, VP Corp Dev
Latest update
What changed recently for Daniel Lang
Latest ownership report period: 16 Sep 2022. Open the source-backed page to inspect the fresh filing or facts context.
Update date
19 Sep 2022
Page type
Ownership filings
Latest period
16 Sep 2022
Ownership context was refreshed from SEC Forms 3/4/5 filed on 19 Sep 2022.
SEC filing record
CIK 0001895384 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
3
First seen
01 Dec 2021
Latest filing
19 Sep 2022
Entity
Individual
Observed form types
4
3
CIK-linked evidence first
Latest Filings
Showing the latest 3 of 3 SEC filings for Daniel Lang.
4
File 001-38112
FORM 4 SUBMISSION
- Filing date
- 19 Sep 2022
- Reporting date
- 16 Sep 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-38112
FORM 4 SUBMISSION
- Filing date
- 21 Jul 2022
- Reporting date
- 20 Jul 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
File 001-38112
FORM 3 SUBMISSION
- Filing date
- 01 Dec 2021
- Reporting date
- 22 Nov 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing